Access to anti-retroviral drugs, male in Gabon

Gabon: Access to anti-retroviral drugs, male was 74.0% in 2024. ◆ Volatile

Latest (2024)
74.0%
Change on year
up 17.5%
World rank
58th
of 141 countries
All-time high
74.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Gabon, 2000–2024

0204060802000201220242000: 0 %2001: 0 %2002: 2 %2003: 3 %2004: 9 %2005: 18 %2006: 20 %2007: 23 %2008: 26 %2009: 32 %2010: 34 %2011: 37 %2012: 41 %2013: 44 %2014: 46 %2015: 46 %2016: 46 %2017: 47 %2018: 47 %2019: 48 %2020: 49 %2021: 51 %2022: 62 %2023: 63 %2024: 74 %

Source: UNAIDS estimates. Measured in %.

Analysis

Gabon recorded 74.0% for access to anti-retroviral drugs, male in 2024. That is the highest value across all 25 years on record.

That represents a change of up 17.5% on the previous year and up 60.9% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Gabon peaked at 74.0% in 2024 and was at its lowest, 0.0%, in 2000.

Gabon ranks 58th of 141 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Gabon, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Gabon, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 2.0%
2003 3.0% +50.0%
2004 9.0% +200.0%
2005 18.0% +100.0%
2006 20.0% +11.1%
2007 23.0% +15.0%
2008 26.0% +13.0%
2009 32.0% +23.1%
2010 34.0% +6.2%
2011 37.0% +8.8%
2012 41.0% +10.8%
2013 44.0% +7.3%
2014 46.0% +4.5%
2015 46.0% +0.0%
2016 46.0% +0.0%
2017 47.0% +2.2%
2018 47.0% +0.0%
2019 48.0% +2.1%
2020 49.0% +2.1%
2021 51.0% +4.1%
2022 62.0% +21.6%
2023 63.0% +1.6%
2024 74.0% +17.5%

Averages by decade

DecadeAverage LowestHighest Years
2000s 13.3% 0.0% 32.0% 10
2010s 43.6% 34.0% 48.0% 10
2020s 59.8% 49.0% 74.0% 5

Countries ranked near Gabon

  1. 55 Congo, Democratic Republic of the 75.0% compare
  2. 55 South Africa 75.0% compare
  3. 55 Viet Nam 75.0% compare
  4. 58 Argentina 74.0% compare
  5. 58 Bahamas 74.0% compare
  6. 58 Malta 74.0% compare

See the full ranking of 160 places →

More gender data for Gabon

All data for Gabon →

Frequently asked questions

What is access to anti-retroviral drugs, male in Gabon?
Access to anti-retroviral drugs, male in Gabon was 74.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Gabon?
The highest recorded value was 74.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Gabon?
The lowest recorded value was 0.0% in 2000.
How does Gabon rank for access to anti-retroviral drugs, male?
Gabon ranks 58th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Gabon?
Over the last ten years it is up 60.9%. The long-run trend across the full record is volatile.
Where does this Gabon data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Gabon. Statizoid, drawing on UNAIDS estimates. Retrieved 08 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/gabon/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/gabon/">Access to anti-retroviral drugs, male in Gabon</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.